Join Wemedoo at the ESMO Congress 2025

Wemedoo will be participating in the ESMO Congress 2025, the world’s premier oncology meeting, taking place in Berlin from October 17 to 21.

The ESMO Congress brings together leading oncologists, researchers, and industry experts from across the globe to share breakthroughs and advance cancer care. With five days of interactive sessions and networking opportunities, ESMO sets the stage for the future of oncology.

Wemedoo’s founder and Chief Product Officer, Nikola Cihoric, MD, RO, will participate, contributing to discussions on innovation in oncology trials and data-driven research.

Date: October 17–21, 2025
Location: Berlin, Germany
Venue: Messe Berlin, Messedamm 22, Berlin, Germany
Website: https://www.esmo.org/